Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Cerebrolysin by EVER Neuro Pharma for Unspecified Neurologic Disorders: Likelihood of Approval
Cerebrolysin is under clinical development by EVER Neuro Pharma and currently in Phase II for Unspecified Neurologic Disorders. According to...